FIELD: medicine.
SUBSTANCE: method involves absorbing myeloma IgA1 on micro panel, incubating solutions containing IgA1-protease and determining enzyme activity from IgA1 sorbate quantity reduction determined by conjugate with polyclonal IgA antibodies peroxidase. Determining IgA1-protease activity with inhibitors available in various concentrations enables one to calculate its inhibition constants. Kit has microplate containing absorbed myeloma IgA1 preparation, peroxidase conjugate with antibodies against human IgA and substrate buffer.
EFFECT: simplified method and kit for determining IgA1-protease activity and studying its inhibition process.
2 cl, 1 dwg, 1tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD AND KIT FOR ENZYME IMMUNOASSAY DETERMINATION OF FUNCTIONAL ACTIVITY OF C1 INHIBITOR BY ABILITY TO BIND WITH IgAl-PROTEASE | 2011 |
|
RU2475756C1 |
IMMUNOENZYME METHOD AND KIT FOR DETERMINING IgA1 AND IgA2 USING POLYCLONAL IgA ANTIBODIES | 2006 |
|
RU2310854C1 |
METHOD AND SET FOR ENZYME IMMUNOASSAY OF EFFECT OF SUBSTANCES ON BINDING C1q COMPLEMENT SUBCOMPONENTS | 2006 |
|
RU2313094C1 |
METHOD AND SET FOR IMMUNOENZYMOMETRIC DETERMINATION OF FUNCTIONAL ACTIVITY OF C1 INHIBITOR ON ALTERNATIVE PATH | 2010 |
|
RU2458346C1 |
METHOD AND KIT FOR ENZYME-LINKED THROMBIN-BINDING ASSAY ON C1 INHIBITOR FUNCTIONAL ACTIVITY | 2011 |
|
RU2477859C1 |
METHOD AND KIT FOR IMMUNOFERMENT DETERMINATION OF PROTEINASE ACTIVITY | 2006 |
|
RU2312352C1 |
METHOD OF ASSAY OF SUBSTANCE EFFECT ON COMPLEMENT IN STAGE OF SUBCOMPONENT C IQ BINDING | 2001 |
|
RU2190219C1 |
METHOD AND SET FOR IMMUNOFERMENTATIVE DETERMINATION OF C1 INHIBITOR BY ABILITY TO BIND WITH DERINAT | 2011 |
|
RU2468369C1 |
METHOD AND KIT FOR QUANTITATIVE IMMUNOASSAY OF HUMAN COMPLEMENT C1 INHIBITOR | 2011 |
|
RU2464566C1 |
METHOD AND KIT FOR QUANTITATIVE IMMUNOASSAY OF HUMAN COMPLEMENT C1 INHIBITOR | 2011 |
|
RU2464567C1 |
Authors
Dates
2007-11-20—Published
2006-07-13—Filed